REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai > Heavy Metal Containing (including Salts) Heavy Metal Containing (including Salts)Heavy Metal Containing (including Salts) patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.01/04/07 - 20070004698 - Pharmaceutical/cosmetic compositions comprising a novel rarbeta receptor-activating ligand and the salts and optical/geometrical isomers thereof are suited for formulation into pharmaceutical compositions useful in human or veterinary medicine, or, alternatively, into cosmetic compositions. ... 01/04/07 - 20070004697 - Monoimine ligand platinum analogs Disclosed herein are novel platinum-based analogs with a single substituted imine ligand: R7RC═NR8, wherein the R7RC═NR8 functional group is covalently bonded to the platinum through nitrogen. The analogs also have nitrogen donor ligands capable of forming hydrogen bonds with the bases in DNA or RNA, and one or more leaving ... 01/04/07 - 20070004696 - Monoazole ligand platinum analogs Disclosed herein are novel platinum-based analogs with a single substituted azole ligand: RN═NR7, wherein the RN═NR7 functional group is covalently bonded to the platinum through nitrogen of NR7. The analogs also have nitrogen donor ligands capable of forming hydrogen bonds with the bases in DNA or RNA, and one or ... 12/21/06 - 20060287288 - Antimicrobial composition useful for preserving wood Antimicrobial compositions useful for preserving wood, and comprising a variety of antimicrobial compounds. ... 11/23/06 - 20060264414 - Fluorous 2,2'-bipyridines and fluorinated biphasic sysems for ligand design A series of 2,2′-bipyridines or 1,10-phenanthrolines featuring alkyl groups appended in the 4,4′ positions or 4,7-positions have been prepared. There is an insulating role of the methylene spacers as the electrochemical reduction potentials of these compounds that is almost identical to that of 2,2′-bipyridine. Calculations for (CH2)nCF3 derivatives (n=0-10) describes ... 11/16/06 - 20060258634 - Ruthenium (ii) complexes for the treatment of tumors Ruthenium (II) compounds of formula (I) are useful in the treatment and/or prevention of cancer. ... 08/24/06 - 20060189589 - 2-methylthiazolidine-2,4-dicarboxylic acid and salts thereof for treatment of neurodegenerative diseases The invention relates to the compounds (2R,4R), (2S,4R)-2-methylthiazolidine-2,4-dicarboxylic acid and (2RS,4R)-2-methylthiazolidine-2,4-dicarboxylic acid and salts of said compounds, the use thereof for the prophylaxis and/or treatment of neurodegenerative diseases, methods for the prophylaxis and/or treatment of neurodegenerative diseases, and pharmaceutical compositions containing said compounds together with physiologically compatible carriers, auxiliary agents, ... 08/17/06 - 20060183729 - Vanadium compounds as anti-angiogenic agents Vanadium compounds for inhibiting angiogenesis useful for treating or preventing diabetic retinopathy, hemangiomas, cancers with abnormal blood vessel supply, restenosis following vascular injury, and the like. ... 08/17/06 - 20060183728 - Combination chemotherapy compositions and methods This invention relates to combination therapies involving anticancer chemotherapeutic agents and isoflavones or analogues thereof. The invention further relates to compounds, compositions, methods and therapeutic uses involving, containing, comprising, including and/or for preparing platinum-isoflavonoid complexes suitable for use in the combination therapies of the invention. ... 08/10/06 - 20060178356 - Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods Cytoprotective compounds, many of which are phenolic derivatives characterized by a substituted phenol having certain conjugated bonds, are useful in the treatment of certain ischemic or inflammatory conditions, including but not limited to stroke, myocardial infarction, congestive heart failure, and skin disorders characterized by inflammation or oxidative damage. They are ... 07/13/06 - 20060154911 - Apoptosis-inducing antineoplastic silver (i) coordination complexes The present invention describes chemotherapeutic compositions, a method for making the same, and methods for inducing apoptosis in tumor cells and/or inhibiting tumors. The compositions are metal coordination complexes of a cytotoxic metal, such as silver(I) and a chiral α-organic acid, such as tartaric acid, in a pharmaceutical carrier. ... 06/29/06 - 20060142259 - Compounds, pharmaceutical compositions and methods for inhibiting hiv infectivity Compounds that possess anti-infective activity are described. Methods of using these compounds for the treatment or prevention of infectious diseases such as acquired immunodeficiency syndrome (AIDS) are also described. The compounds inhibit HIV infectivity and do not exhibit significant cytotoxicity in HIV producing cells. ... 06/15/06 - 20060128682 - Compounds and methods for the treatment of cancer The present invention provides organic arsenicals. Many of these compounds have potent in vitro cytotoxic activity against numerous human tumor cell lines, both of solid and hematological origin, as well as against malignant blood cells from patients with leukemia. ... 06/15/06 - 20060128681 - Novel rho inhibitors Rho is an enzyme essential for the growth and survival of Escherichia coli, and bicyclomycin is its only known selective inhibitor. The site and pathway of rho inhibition by the putative metal thiol chelates are disclosed. Additionally compositions and methods of divalent metals and compounds containing a thiol group are ... 05/18/06 - 20060106006 - Vanadium compounds for treating cancer The invention provides methods for treating cancer and compounds that are useful for the treatment of tumors, as well as pharmaceutical compositions comprising the compounds, and synthetic methods and intermediates useful for preparing the compounds. ... 05/18/06 - 20060106005 - Funtionalised metallocenes as anticancer drugs wherein R1, R2, R3 and R4 represent a combination of H, alkyl, aryl or trimethylsilyl; L represents side chain substituents, at least one of which contains a group which enables the compound to become water-solubilised; X is halo, alkoxy, acetate or H2O; Y is a counter-ion; M is a metal; ... 04/27/06 - 20060089342 - Topical anti-microbial compositions Disclosed are topical compositions for the treatment of microbial infections on the skin or scalp which include a polyvalent metal salt of pyrithione and include a metal ion source. Also disclosed are methods for treating microbial infections of the skin or scalp using such compositions. ... 04/27/06 - 20060089341 - Protein-bound derivatives of platinum complexes containing cyclobutane1,1-dicarboxyllate ligands The invention concerns low-molecular platinum complexes containing cyclobutane-1,1-dicarboxylate ligands that contain a protein-binding group. ... 04/13/06 - 20060079495 - Diagnosis and treatment system for reward deficiency syndrome (rds) and related behaviors The present invention relates to a kit and an intravenously administrable preparation, both with a signal transmitter precursor, an enhancer of precursor uptake, and an inhibitor of neurotransmitter reuptake or signal transmitter catabolism. The kit also contains an appropriate swab for obtaining oral cells suitable for allelic analysis. The intravenous ... 04/06/06 - 20060074063 - Pharmacological agent and method of treatment An antiproliferative, antiinflammatory, antiinfective, immunization agent of a metal ion chelating agent such as picolinic acid, analogs or derivatives thereof, and methods of using the same. The agents chelate metals in metal containing protein complexes and enzymes required for growth, replication or inflammatory response. The preparations can be administered systemically ... 03/09/06 - 20060052357 - Organometallic anti-tumour agent where D is a β-diketone, M is a metal atom and T is a substance having at least one N-, O- or S-containing group, and to the use thereof as antitumor agents. ... 02/16/06 - 20060035880 - Superoxide dismutase mimics for the treatment of ocular disorders and diseases The use of SOD mimics, particularly Mn(III) salen SOD mimics, for the treatment of AMD, DR, and retinal edema is disclosed. ... 02/02/06 - 20060025398 - Topical antiviral therapeutic and prophylactic treatment of adenoviruses and their associated diseases A method for the therapeutic and prophylactic treatment of adeviruses, More specifically, a method for the therapeutic treatment of adenovirus in a subject by topically administering an antiviral effective amount of CTC-96 to the subject. In addition, a method for the prophylactic treatment against an adenovirus infection in a subject ... 02/02/06 - 20060025397 - Method of resistance of epilepsy by suppressing the function of alpha 1g protein The disclosure concerns a method for resistance of epilepsy by suppressing the function of alpha 1 G protein of T-type calcium channels, use of suppressor of alpha 1 G protein for prevention or treatment for epilepsy, knockout mice resisting epilepsy by disrupting alpha 1 G subunit of T-type calcium channel, ... 01/05/06 - 20060003981 - Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium. ... 01/05/06 - 20060003980 - Cobalt(ii) complexes as protein tyrosine kinase inhibitors Various cobalt (II) complexes are able to selectively inhibit the protein tyrosine kinases (PTKs). These complexes are useful in the treatment of various diseases including hyperproliferative diseases, hematologic diseases, osteoporosis, neurological diseases, autoimmune diseases, allergic/immunological diseases, or viral infections. ... 12/22/05 - 20050282794 - Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium. ... 12/08/05 - 20050272713 - Supramolecular complexes as photoactivated dna cleavage agents The invention provides supramolecular metal complexes as DNA cleaving agents. In the complexes, charge is transferred from one light absorbing metal (e.g. Ru or Os) to an electron accepting metal (e.g. Rh) via a bridging π-acceptor ligand. A bioactive metal-to-metal charge transfer state capable of cleaving DNA is thus generated. ... 12/01/05 - 20050267089 - Polycyclic pyrimidines as potassium ion channel modulators The present invention provides a genus of polycyclic pyrimidines that are useful as modulators of potassium ion channels. The modulators of the invention are of use in both therapeutic and diagnostic methods. ... 11/24/05 - 20050261264 - Rare-earth ternary complex wherein M is a rare earth atom; n1 is 2 or 3; n2 is 2, 3, or 4; Rf1 and Rf2 are the same or different and are each a aliphatic group having 1 to 22 carbon atoms and containing no hydrogen atoms, an aromatic group containing no hydrogen atoms, ... 11/10/05 - 20050250754 - Method of forming iron hydroxypyrone compounds A method of forming an iron hydroxypyrone compound comprising reacting an iron salt of a carboxylic acid and a hydroxypyrone in an aqueous solution at a pH greater than 7. ... 10/27/05 - 20050239765 - Half-sandwich ruthenium (ii) compounds comprising nitrogen containing ligands for treatment of cancer Compounds which may be used in the treatment and/or prevention of cancer have the formula (I) wherein: R1, R2, R3, R4, R5 and R6 independently represents H, alkyl, —CO2R′, aryl or akylaryl, which latter two groups are optionally substituted on the aromatic ring; R′ represent alkyl, aryl or alkaryl; X ... 10/27/05 - 20050239764 - Zinc pyrrolidonecarboxylate dihydrate and method of producing the same The present invention aims at providing a convenient method of producing zinc pyrrolidonecarboxylate dihydrate, which is an industrially useful compound, with high optical purity, a higher yield, and better dissolution property. The present invention also provides a convenient method of producing zinc pyrrolidonecarboxylate dihydrate with higher optical purity, a higher ... 10/27/05 - 20050239763 - Non-gmo metal amino acid chelates and non-gmo metal amino acid chelate-containing compositions Non-GMO metal amino acid chelate compositions, non-GMO formulations containing non-GMO metal amino acid chelates, methods of preparing non-GMO metal amino acid chelates, and methods of administering non-GMO metal amino acid chelates are provided. Specifically, the present invention provides a non-GMO metal amino acid chelate composition, comprising amino acid chelates having ... 10/13/05 - 20050227956 - Control of mold growth on wood A composition comprising a copper compound, a quaternary ammonium compound, an alkanolamine or ammonia, a carbonate, and at least two moldicides wherein the total concentration of moldicides is a maximum of 80 mg per liter, said composition effective to prevent mold growth in pressure treated wood. ... 09/01/05 - 20050192266 - Vanadium (iv) metallocene complexes having spermicidal activity Novel spermicidal compounds which are organometallic cyclopentadienyl metal complexes, particularly vanadium IV complexes, are described including corresponding contraceptive and therapeutic compositions and method for providing contraception and selective killing of testicular germ cells. Included among the vanadium complexes are vanadocene dichloride, vanadocene dibromide, bis (methyl cyclopentadienyl) vanadium dichloride, vanadocene diiodide, ... 06/02/05 - 20050119243 - Hif-1 inhibitors and methods of use thereof Methods of treating cancer or tumor, chemopreventative methods of prophylactically treating cancers or tumors, pharmaceutical compositions, methods for the treatment or prevention of a hypoxia-related pathology, methods of modulating HIF-1 activity in a cell, methods of downregulating HIF-1 activity in a cell, methods of treating or preventing cancer or a ... ### FreshPatents.com Support |